This company listing is no longer active
G Medical Innovations Holdings Crecimiento futuro
Future controles de criterios 3/6
Información clave
80.4%
Tasa de crecimiento de los beneficios
n/a
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Healthcare | 21.0% |
| Tasa de crecimiento de los ingresos | n/a |
| Rentabilidad financiera futura | n/a |
| Cobertura de analistas | Low |
| Última actualización | 20 May 2022 |
Actualizaciones recientes sobre el crecimiento futuro
Recent updates
Previsiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 12/31/2023 | 20 | -4 | N/A | N/A | 1 |
| 6/30/2022 | 4 | -23 | -29 | -27 | N/A |
| 3/31/2022 | 5 | -19 | -21 | -19 | N/A |
| 12/31/2021 | 5 | -15 | -12 | -11 | N/A |
| 9/30/2021 | 5 | -14 | -8 | -7 | N/A |
| 6/30/2021 | 6 | -12 | -4 | -3 | N/A |
| 3/31/2021 | 5 | -12 | -4 | -4 | N/A |
| 12/31/2020 | 5 | -13 | -5 | -5 | N/A |
| 9/30/2020 | 5 | -13 | -5 | -5 | N/A |
| 6/30/2020 | 5 | -13 | -5 | -4 | N/A |
| 3/31/2020 | 5 | -14 | -6 | -5 | N/A |
| 12/31/2019 | 6 | -15 | -7 | -6 | N/A |
| 9/30/2019 | 5 | -15 | -9 | -9 | N/A |
| 6/30/2019 | 5 | -15 | -11 | -11 | N/A |
| 3/31/2019 | 4 | -15 | -15 | -13 | N/A |
| 12/31/2018 | 3 | -16 | -18 | -15 | N/A |
| 9/30/2018 | 2 | -15 | -18 | -15 | N/A |
| 6/30/2018 | 1 | -14 | -18 | -14 | N/A |
| 3/31/2018 | 1 | -20 | -14 | -11 | N/A |
| 12/31/2017 | 0 | -27 | -10 | -8 | N/A |
| 9/30/2017 | 0 | -26 | -7 | -6 | N/A |
| 6/30/2017 | N/A | -24 | -5 | -4 | N/A |
| 3/31/2017 | N/A | -13 | -4 | -3 | N/A |
| 12/31/2016 | N/A | -3 | -3 | -3 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: 9GM0 is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.2%).
Beneficios vs. Mercado: 9GM0 is forecast to become profitable over the next 3 years, which is considered above average market growth.
Beneficios de alto crecimiento: 9GM0 is expected to become profitable in the next 3 years.
Ingresos vs. Mercado: Insufficient data to determine if 9GM0's revenue is forecast to grow faster than the German market.
Ingresos de alto crecimiento: Insufficient data to determine if 9GM0's revenue is forecast to grow faster than 20% per year.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Insufficient data to determine if 9GM0's Return on Equity is forecast to be high in 3 years time